精准医学背景下血管内皮损伤修复的 研究进展
Research Progress on Vascular Endothelial Injury Repair in the Context of Precision Medicine
DOI: 10.12677/acm.2026.1672501, PDF,    科研立项经费支持
作者: 荣汐玥:重庆医科大学第二临床学院,重庆;张 瑜*:重庆医科大学附属第二医院放射科,重庆
关键词: 血管内皮损伤修复心血管疾病分子影像学精准医学Vascular Endothelial Injury Repair Cardiovascular Disease Molecular Imaging Precision Medicine
摘要: 血管内皮损伤(VEI)被认为是诸多心血管疾病(CVD)的关键始动环节,严重危害人类健康与生命安全。因此,如何实现VEI的早期、高效修复,已成为当前的研究热点与难点。本文首先阐述了VEI的核心病理机制,包括线粒体氧化应激、炎症反应的持续性激活及一氧化氮合成减少等,明确指出VEI是多种病理刺激共同作用的结果。在此基础上,重点综述了针对VEI的精准靶向治疗修复策略及前沿研究进展,包括靶向清除活性氧、靶向阻断炎症信号通路及提升一氧化氮利用度/产量。此外,本文还探讨了分子影像学在实现VEI早期可视化检测与诊疗一体化中的可行性。希望通过多个角度的解析,促进精准医学在VEI修复中的发展,为CVD患者带来更好的治疗前景。
Abstract: Vascular endothelial injury (VEI) is recognized as a critical initiating event in cardiovascular disease (CVD), posing severe threats to human health and survival. Consequently, achieving early and efficient repair of VEI has emerged as both a research hotspot and a significant challenge. This article first elucidates the core pathological mechanisms of VEI—including mitochondrial oxidative stress, sustained activation of inflammatory responses, and reduced nitric oxide synthesis—emphasizing that VEI results from the synergistic effects of multiple pathological stimuli. Building upon this foundation, we comprehensively review precision-targeted therapeutic strategies and cutting-edge advances in VEI repair, specifically focusing on targeted reactive oxygen species (ROS) scavenging, blockade of inflammatory signaling pathways, and enhancement of nitric oxide bioavailability and production. Furthermore, we explore the feasibility of molecular imaging in enabling early visual detection and theranostics for VEI. Through this multidimensional analysis, we aim to advance precision medicine in VEI repair and offer improved therapeutic prospects for patients with CVD.
文章引用:荣汐玥, 张瑜. 精准医学背景下血管内皮损伤修复的 研究进展[J]. 临床医学进展, 2026, 16(7): 89-95. https://doi.org/10.12677/acm.2026.1672501

参考文献

[1] 刘明波, 何新叶, 杨晓红, 等. 《中国心血管健康与疾病报告2024》要点解读[J]. 实用医学杂志, 2025, 41(14): 2111-2131.
[2] Augustin, H.G. and Koh, G.Y. (2024) A Systems View of the Vascular Endothelium in Health and Disease. Cell, 187, 4833-4858. [Google Scholar] [CrossRef] [PubMed]
[3] Pepin, M.E. and Gupta, R.M. (2024) The Role of Endothelial Cells in Atherosclerosis: Insights from Genetic Association Studies. The American Journal of Pathology, 194, 499-509. [Google Scholar] [CrossRef] [PubMed]
[4] 高海钧, 任佳禹, 王若琳, 等. 内皮细胞损伤及其功能障碍在动脉粥样硬化中作用的研究进展[J]. 中国全科医学, 2025, 28(21): 2697-2704.
[5] Singh, J., Stanley, C.P. and Kavurma, M.M. (2026) Endothelial Mitochondrial Dysfunction in Hypertension, Diabetes, and Atherosclerosis. Cardiovascular Research, 122, 19-32. [Google Scholar] [CrossRef
[6] Xia, X.D., Peng, Z.S., Gu, H.M., Wang, M., Wang, G. and Zhang, D. (2021) Regulation of PCSK9 Expression and Function: Mechanisms and Therapeutic Implications. Frontiers in Cardiovascular Medicine, 8, Article ID: 764038. [Google Scholar] [CrossRef] [PubMed]
[7] Li, Y., Zou, W., Zhang, Y., Qi, Z., Wang, Q., Jia, Z., et al. (2026) Gualou Huoxue Jiedu Decoction Inhibits VSMC Phenotypic Switching to Alleviate Atherosclerosis via Promoting Mfap4 DNA Methylation. Phytomedicine, 153, Article 157881. [Google Scholar] [CrossRef
[8] Jana, S. (2019) Endothelialization of Cardiovascular Devices. Acta Biomaterialia, 99, 53-71. [Google Scholar] [CrossRef] [PubMed]
[9] Inoue, T., Croce, K., Morooka, T., Sakuma, M., Node, K. and Simon, D.I. (2011) Vascular Inflammation and Repair: Implications for Reendothelialization, Restenosis, and Stent Thrombosis. JACC: Cardiovascular Interventions, 4, 1057-1066. [Google Scholar] [CrossRef] [PubMed]
[10] Zhong, Y., Ni, Q., Huang, L., Qing, G., Zhang, F., Gong, N., et al. (2025) Prevention of Acute Thrombosis with Vascular Endothelium Antioxidative Nanoscavenger. Nature Nanotechnology, 20, 1871-1883. [Google Scholar] [CrossRef
[11] Zeng, Z., He, X., Li, C., Lin, S., Chen, H., Liu, L., et al. (2021) Oral Delivery of Antioxidant Enzymes for Effective Treatment of Inflammatory Disease. Biomaterials, 271, Article 120753. [Google Scholar] [CrossRef] [PubMed]
[12] Qu, Y., Zhang, J., Ou, H., Yan, Y., Zhang, R. and Sun, J. (2026) Hyaluronic Acid Engineered Melanin-MOF Nanoreactor Synergistically Remodeling Redox and Immune Homeostasis for Targeted Acute Lung Injury Therapy. Materials Today Bio, 37, Article 102954. [Google Scholar] [CrossRef
[13] Zhang, W., Wang, J., Xie, Z., Zou, H., Chen, Q., Xu, L., et al. (2022) Antithrombotic Therapy by Regulating the Ros‐mediated Thrombosis Microenvironment and Specific Nonpharmaceutical Thrombolysis Using Prussian Blue Nanodroplets. Small, 18, Article 2106252. [Google Scholar] [CrossRef] [PubMed]
[14] Song, J., Kang, X., Yang, S., Meng, X., Shi, Z., Li, W., et al. (2026) A Hierarchical Theranostic Nanoagent for Multimodal Imaging and Targeted Foam Cell Intervention in Atherosclerosis. Nature Communications, 17, Article No. 3794. [Google Scholar] [CrossRef
[15] Liu, J., Chen, S., Zhang, W., Xu, Z., Liu, Y., Rong, X., et al. (2025) A Biomimetic Nanoplatform for Endogenous Self-Replenishing of Oxygen to Promote Sonodynamic Therapy for Targeted Ablation of Activated Macrophages in Atherosclerotic Plaques. Materials Today Bio, 35, Article 102338. [Google Scholar] [CrossRef
[16] Sun, X., Icli, B., Wara, A.K., Belkin, N., He, S., Kobzik, L., et al. (2012) MicroRNA-181b Regulates NF-κB-Mediated Vascular Inflammation. Journal of Clinical Investigation, 122, 1973-1990. [Google Scholar] [CrossRef] [PubMed]
[17] 张春敏, 杨文敏, 林永敏, 等. 乌司他丁调控NF-κB信号通路对脓毒症急性肾损伤作用机制研究[J]. 中华急诊医学杂志, 2023, 32(12): 1680-1685.
[18] Ridker, P.M., Everett, B.M., Thuren, T., MacFadyen, J.G., Chang, W.H., Ballantyne, C., et al. (2017) Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. New England Journal of Medicine, 377, 1119-1131. [Google Scholar] [CrossRef] [PubMed]
[19] Hemenway, G. and Frishman, W.H. (2022) Therapeutic Implications of NLRP3-Mediated Inflammation in Coronary Artery Disease. Cardiology in Review, 30, 90-99. [Google Scholar] [CrossRef] [PubMed]
[20] Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., et al. (2024) NF-κB in Biology and Targeted Therapy: New Insights and Translational Implications. Signal Transduction and Targeted Therapy, 9, 53-89. [Google Scholar] [CrossRef] [PubMed]
[21] Rashid, J., Kumar, S.S., Job, K.M., Liu, X., Fike, C.D. and Sherwin, C.M.T. (2020) Therapeutic Potential of Citrulline as an Arginine Supplement: A Clinical Pharmacology Review. Pediatric Drugs, 22, 279-293. [Google Scholar] [CrossRef] [PubMed]
[22] Kelly, K.A., Heaps, C.L., Wu, G., Labhasetwar, V. and Meininger, C.J. (2024) Nanoparticle-Mediated Delivery of Tetrahydrobiopterin Restores Endothelial Function in Diabetic Rats. Nitric Oxide, 148, 13-22. [Google Scholar] [CrossRef] [PubMed]
[23] Lu, L., Jang, S., Zhu, J., Qin, Q., Sun, L. and Sun, J. (2024) Nur77 Mitigates Endothelial Dysfunction through Activation of Both Nitric Oxide Production and Anti-Oxidant Pathways. Redox Biology, 70, Article 103056. [Google Scholar] [CrossRef] [PubMed]